AquaBounty reports loss in latest financial results

(11/08/18)

Maynard, Mass.-based biotechnology company AquaBounty announced its financial results for the third quarter and nine months ended Sept. 30, 2018.

The company stated in the financial and operational summary that it began production operations at its Indiana farm with traditional Atlantic salmon eggs while waiting for approval from the U.S. Food and Drug Administration (FDA) to import AquAdvantage Salmon eggs.

“In this quarter, we commenced grow-out of non-transgenic Atlantic salmon at our site in Albany, Ind., which will allow us to begin utilizing this facility and to make any necessary adjustments to our processes or standard operating procedures while we.........................................................


Click here to read the rest of this article:
https://www.aquaculturenorthamerica.com/news/